E722-2648

E722-2648 is a small molecule that potently inhibits Wnt signaling by disrupting the β-catenin/BCL9 interaction. This action leads to altered cholesterol metabolism and demonstrates antitumor efficacy in preclinical cancer models, supporting its use as a research tool for oncology and pathway studies.